These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30670494)

  • 1. The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity.
    Digomann D; Kurth I; Tyutyunnykova A; Chen O; Löck S; Gorodetska I; Peitzsch C; Skvortsova II; Negro G; Aschenbrenner B; Eisenhofer G; Richter S; Heiden S; Porrmann J; Klink B; Schwager C; Dowle AA; Hein L; Kunz-Schughart LA; Abdollahi A; Lohaus F; Krause M; Baumann M; Linge A; Dubrovska A
    Clin Cancer Res; 2019 May; 25(10):3152-3163. PubMed ID: 30670494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed.
    Digomann D; Linge A; Dubrovska A
    Autophagy; 2019 Oct; 15(10):1850-1851. PubMed ID: 31276435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profile of CD98 heavy chain and L-type amino acid transporter 1 and its prognostic significance in colorectal cancer.
    Lee D; Kim HS; Kim HU; Song HJ; Lee C; Kim DY; Chun HM; Jang WY; Jang B
    Pathol Res Pract; 2022 Jan; 229():153730. PubMed ID: 34942513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino Acid Transport Associated to Cluster of Differentiation 98 Heavy Chain (CD98hc) Is at the Cross-road of Oxidative Stress and Amino Acid Availability.
    de la Ballina LR; Cano-Crespo S; González-Muñoz E; Bial S; Estrach S; Cailleteau L; Tissot F; Daniel H; Zorzano A; Ginsberg MH; Palacín M; Féral CC
    J Biol Chem; 2016 Apr; 291(18):9700-11. PubMed ID: 26945935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aryl hydrocarbon receptor-dependent up-regulation of the heterodimeric amino acid transporter LAT1 (SLC7A5)/CD98hc (SLC3A2) by diesel exhaust particle extract in human bronchial epithelial cells.
    Le Vee M; Jouan E; Lecureur V; Fardel O
    Toxicol Appl Pharmacol; 2016 Jan; 290():74-85. PubMed ID: 26621329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Linge A; Lohaus F; Löck S; Nowak A; Gudziol V; Valentini C; von Neubeck C; Jütz M; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Buchholz F; Aust DE; Baretton GB; Thames HD; Dubrovska A; Alsner J; Overgaard J; Krause M; Baumann M;
    Radiother Oncol; 2016 Dec; 121(3):364-373. PubMed ID: 27913065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc.
    Lee Y; Wiriyasermkul P; Jin C; Quan L; Ohgaki R; Okuda S; Kusakizako T; Nishizawa T; Oda K; Ishitani R; Yokoyama T; Nakane T; Shirouzu M; Endou H; Nagamori S; Kanai Y; Nureki O
    Nat Struct Mol Biol; 2019 Jun; 26(6):510-517. PubMed ID: 31160781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drosophila expresses a CD98 transporter with an evolutionarily conserved structure and amino acid-transport properties.
    Reynolds B; Roversi P; Laynes R; Kazi S; Boyd CA; Goberdhan DC
    Biochem J; 2009 May; 420(3):363-72. PubMed ID: 19335336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD98 increases renal epithelial cell proliferation by activating MAPKs.
    Bulus N; Feral C; Pozzi A; Zent R
    PLoS One; 2012; 7(6):e40026. PubMed ID: 22768207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer.
    Ichinoe M; Mikami T; Yanagisawa N; Yoshida T; Hana K; Endou H; Okayasu I; Sengoku N; Ogata H; Saegusa M; Shibuya K; Murakumo Y
    J Clin Pathol; 2021 Sep; 74(9):589-595. PubMed ID: 32907912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
    Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
    J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma.
    Köseer AS; Loureiro LR; Jureczek J; Mitwasi N; González Soto KE; Aepler J; Bartsch T; Feldmann A; Kunz-Schughart LA; Linge A; Krause M; Bachmann M; Arndt C; Dubrovska A
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD98 heavy chain as a prognostic biomarker and target for cancer treatment.
    Xia P; Dubrovska A
    Front Oncol; 2023; 13():1251100. PubMed ID: 37823053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIPRL1 and its ATM-dependent phosphorylation promote radiotherapy resistance in head and neck cancer.
    Cokelaere C; Dok R; Cortesi EE; Zhao P; Sablina A; Nuyts S; Derua R; Janssens V
    Cell Oncol (Dordr); 2024 Jun; 47(3):793-818. PubMed ID: 37971644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
    Nguyen NNT; Lim YS; Nguyen LP; Tran SC; Luong TTD; Nguyen TTT; Pham HT; Mai HN; Choi JW; Han SS; Hwang SB
    Sci Rep; 2018 Oct; 8(1):15486. PubMed ID: 30341327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD98hc (SLC3A2) sustains amino acid and nucleotide availability for cell cycle progression.
    Cano-Crespo S; Chillarón J; Junza A; Fernández-Miranda G; García J; Polte C; R de la Ballina L; Ignatova Z; Yanes Ó; Zorzano A; Stephan-Otto Attolini C; Palacín M
    Sci Rep; 2019 Oct; 9(1):14065. PubMed ID: 31575908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of lncRNA BLACAT1 enhances radiosensitivity of head and neck squamous cell carcinoma cells by regulating PSEN1.
    Gou C; Han P; Li J; Gao L; Ji X; Dong F; Su Q; Zhang Y; Liu X
    Br J Radiol; 2020 Apr; 93(1108):20190154. PubMed ID: 31944856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L.
    Nathansen J; Lukiyanchuk V; Hein L; Stolte MI; Borgmann K; Löck S; Kurth I; Baumann M; Krause M; Linge A; Dubrovska A
    Oncogene; 2021 Jun; 40(24):4214-4228. PubMed ID: 34079088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CD98 heavy chain in cancer development.
    Park E; Kim H; Yoon S; Jang B
    Histol Histopathol; 2024 Apr; ():18749. PubMed ID: 38695393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer.
    Alfarsi LH; El-Ansari R; Craze ML; Masisi BK; Mohammed OJ; Ellis IO; Rakha EA; Green AR
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.